Impact of Vasculitis on Employment and Income
NCT02476292 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 426
Last updated 2016-01-28
Summary
The purpose of this study is to learn about the impact of vasculitis on employment and income in patients with different systemic vasculitides. All patients enrolled in the Vasculitis Clinical Research Consortium (VCRC) Patient Contact Registry, living in USA or Canada, and followed for more than 1 year since the vasculitis diagnosis will be invited via email to participate in this study, based on an online survey.
Conditions
- Vasculitis
- Systemic Vasculitis
- Behcet's Disease
- CNS Vasculitis
- Cryoglobulinemic Vasculitis
- Eosinophilic Granulomatosis
- Temporal Arteritis
- Wegener Granulomatosis
- Henoch-Schoenlein Purpura
- Microscopic Polyangiitis
- Polyarteritis Nodosa (PAN)
- Takayasu's Arteritis
- Urticarial Vasculitis
Interventions
- OTHER
-
online questionnaire
The online questionnaire includes questions about vasculitis, employment and work status before diagnosis and over the course of the disease, work capacity and the financial impact of vasculitis.
Sponsors & Collaborators
-
University of Western Ontario, Canada
collaborator OTHER - collaborator OTHER
-
University of Toronto
collaborator OTHER -
University of South Florida
lead OTHER
Principal Investigators
-
Christian Pagnoux, MD, MPH, MSc · University of Toronto
-
Peter A. Merkel, MD, MPH · University of Pennsylvania
-
Lillian Barra, MD, PhD · University of Western Ontario, Canada
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
Countries
- United States
Study Locations
More Related Trials
-
VCRC Tissue Repository
NCT02967068 ·Status: RECRUITING
-
Reproductive Health in Men and Women With Vasculitis
NCT02176070 ·Status: COMPLETED
-
Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
NCT00315393 ·Status: COMPLETED
-
One-Time DNA Study for Vasculitis
NCT01241305 ·Status: RECRUITING
-
Belimumab in Remission of VASculitis
NCT01663623 ·Status: COMPLETED ·Phase: PHASE3
-
The ANCA Vasculitis Questionnaire (AAV-PRO©)
NCT02507024 ·Status: COMPLETED
-
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
NCT00104299 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Biocollection of Patients With ANCA Associated Vasculitis
NCT05364892 ·Status: RECRUITING ·Phase: NA
-
Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
NCT00315497 ·Status: COMPLETED
-
Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis
NCT00001541 ·Status: COMPLETED
-
A Randomized Multicenter Study for Isolated Skin Vasculitis
NCT02939573 ·Status: RECRUITING ·Phase: PHASE2
-
Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)
NCT01934504 ·Status: TERMINATED
-
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
NCT00059748 ·Status: RECRUITING
-
PRO Development for ANCA Associated Vasculitis
NCT01729624 ·Status: UNKNOWN
-
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)
NCT01862068 ·Status: COMPLETED
-
Pediatric Vasculitis Initiative
NCT02006134 ·Status: RECRUITING
-
Multicenter Cohort Study of AAV in Hunan of China
NCT05315141 ·Status: RECRUITING
-
Hematopoietic Stem Cell Support in Vasculitis
NCT00278512 ·Status: TERMINATED ·Phase: PHASE1
-
Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing
NCT02749292 ·Status: TERMINATED ·Phase: PHASE4
-
Aetiology of TemporaL Arteritis Study
NCT02584517 ·Status: WITHDRAWN
-
Autoimmune and Autoinflammatory Genetics Study
NCT06004349 ·Status: RECRUITING
-
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
NCT00468208 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723 ·Status: RECRUITING ·Phase: PHASE2
-
Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
NCT01731561 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
NCT02169219 ·Status: COMPLETED ·Phase: PHASE4